|View printer-friendly version|
|Quidel to Present at the S.G. Cowen 24th Annual Health Care Conference on March 10, 2004 at 11:15 a.m. EST|
SAN DIEGO--(BUSINESS WIRE)--March 8, 2004--Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, today announced that president and chief executive officer, S. Wayne Kay, will be a presenter at S.G. Cowen's 24th Annual Health Care Conference in Boston on Wednesday, March 10, 2004 at 11:15 a.m. Eastern time.
Investors may access an Internet webcast of the presentation live on the Company's Web site at www.quidel.com in the Investor Information section. The webcast of the presentation and Q&A will be available for 30 days at the above Web address.
Quidel Corporation, a worldwide company helping women and their families live healthy lives, discovers, develops, manufactures and markets rapid point-of-care (POC) diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions associated with women's health in areas such as reproduction, upper respiratory infections and other clinical conditions. Quidel provides a broad line of POC diagnostics for pregnancy and infectious diseases, including influenza A and B, Strep throat, pregnancy, H. pylori infection, chlamydia, infectious mononucleosis and infectious vaginitis. Quidel's products are sold to healthcare professionals for use in physician offices, clinical laboratories and to consumers through several distribution partners. For more information, please visit www.quidel.com.
CONTACT: Quidel Corporation